510(k) Report

510(k) · Cleared

Cleared

Advanced Perfusion System 1

K163531510(k) TraditionalCleared Jun 7, 2017173-day reviewClass II21 CFR 870.4220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Terumo Cardiovascular Systems Corporation · DTQ Console, Heart-Lung Machine, Cardiopulmonary Bypass

Cleared on Jun 7, 2017 as substantially equivalent to K153376 (Terumo Cardiovascular Systems Corporation, 2015) after a 173-day review. Its family tree reaches back 6 generations to 1992. 2 later devices descend from it.

Decided
Jun 7, 2017
Review
173 days
Class
Class II
Product code
DTQ
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K915183 (1992). 10 ancestors in all, the oldest K871131 (1987). 2 later devices descend from it, 1 citing it directly.

  1. Root · 6 generations backK915183 Sarns 8000 Modular Perfusion System3M Health Care, Sarns · 1992 · Recalled
  2. 5 generations backK953901 Sarns 800 Roller Pump3M Health Care, Sarns · 1996
  3. 4 generations backK022947 Advanced Perfusion System 1 (100/120 Volt),Advanced Perfusion System…Terumo Cardiovascular Systems Corp. · 2003 · Recalled
  4. 3 generations backK131041 Advanced Perfusion System 1Terumo Cardiovascular Systems Corp. · 2014
  5. 2 generations backK151349 Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation · 2015
  6. 1 generation backK153376 Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation · 2015 · Recalled
  7. This deviceK163531 Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation · 2017
  8. Descendant · cites it directly · 1 of its ownK172220 Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation · 2017 · Recalled
  9. Descendant · 2 generations on · 0 of its ownK221895 Terumo Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation · 2023

Most influential descendants

Showing 2 of 2 · See all
  • K172220Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation · 2017 · cites it directly1descendant
  • K221895Terumo Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation · 2023 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K915183Sarns 8000 Modular Perfusion System3M Health Care, Sarns199245
−5K953901Sarns 800 Roller Pump3M Health Care, Sarns1996—
−4K022947Advanced Perfusion System 1 (100/120 Volt),Advanced Perfusion System 1…Terumo Cardiovascular Systems Corp.2003150
−3K131041Advanced Perfusion System 1Terumo Cardiovascular Systems Corp.2014—
−2K151349Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation2015—
−1K153376Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation20152
0 (this device)K163531Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation2017—
+1K172220Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation201714
+2K221895Terumo Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation2023—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199510
199610
201110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
202310
FIG. 1 — Lineage of K163531, 1992–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DTQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DTQ device

  1. #1 K221373 Essenz HLMscore 8.9 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K153376Advanced Perfusion System 1
Summary page 4
…Terumo® Advanced Perfusion System 1 is substantially equivalent in function and intended use to the Terumo® Advanced Perfusion System 1 cleared in Premarket Notification K153376. May 3, 2017 Page 1 of 6…
Terumo Cardiovascular Systems Corporation20152

Also cleared against K153376: 1 other device →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172220Advanced Perfusion System 1Terumo Cardiovascular Systems Corporation20171

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 3 companies; a new generation was cleared every 3.8 years on median.
  • 5 of the 10 ancestors have a recall of any class.
  • Of its descendants, K172220 (Terumo Cardiovascular Systems Corporation, 2017) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K153376.

How does its category compare?

All DTQ devices

DTQ Console, Heart-Lung Machine, Cardiopulmonary Bypass: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · DTQ

3in 2023

2007: 22008: 12009: 32010: 12011: 22014: 22015: 22017: 22018: 12019: 12021: 22023: 3
2007high 3 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTQ

292in 2023

2009: 86 days median2023: 292 days median
2007high 292 (2023) · low 86 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DTQ

1in 2024

2007: 92008: 172009: 12010: 172011: 222012: 422013: 42014: 12018: 12019: 1, 1 Class I2022: 12023: 7, 1 Class I2024: 1
2007high 42 (2012) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · DTQ

1,014in 2025

2007: 4202008: 5482009: 5892010: 8112011: 1,0812012: 1,6262013: 9062014: 1,2902015: 1,1842016: 7142017: 5272018: 6762019: 8572020: 6272021: 7292022: 7172023: 8182024: 8632025: 1,014
2007high 1,626 (2012) · low 420 (2007)2025

MAUDE reports naming product code DTQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—9420
20081—17548
20093861589
20101—17811
20112—221,081
20120—421,626
20130—4906
20142—11,290
20152—01,184
20160—0714
20172—0527
20181—1676
20191—1 (1)857
20200—0627
20212—0729
20220—1717
202332927 (1)818
20240—1863
20250—01,014
20260—0—

What is it indicated for?

The Terumo® Advanced Perfusion System 1 is indicated for use for up to 6 hours in the extracorporeal circulation of

blood for arterial perfusion, regional perfusion, and cardiopulmonary bypass procedures, when used by a qualified

medical professional who is experienced in the operation of this or similar equipment.

The centrifugal pump is indicated for use in cardiopulmonary bypass procedures only.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K163531: Advanced Perfusion System 1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K163531

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026